Chargement en cours...
Biophysical Differences between Chronic Myelogenous Leukemic Quiescent and Proliferating Stem/Progenitor Cells
The treatment of chronic myeloid leukemia (CML), a clonal myeloproliferative disorder has improved recently, but most patients have not yet been cured. Some patients develop resistance to the available tyrosine kinase treatments. Persistence of residual quiescent CML stem cells (LSC) that later resu...
Enregistré dans:
| Publié dans: | Nanomedicine |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5116407/ https://ncbi.nlm.nih.gov/pubmed/27431055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.06.016 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|